West Pharmaceutical Services Inc (WST)

241.19 +7.91  +3.39% NYSE Jul 15, 16:58 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
10/23/2020 09:00 EDT Misc West Pharmaceutical Services Inc Third Quarter Earnings Conference Call for 2020
10/23/2020 Earnings West Pharmaceutical Services Inc Third Quarter Earnings for 2020 Release
07/23/2020 09:00 EDT Misc West Pharmaceutical Services Inc Second Quarter Earnings Conference Call for 2020
07/23/2020 Earnings West Pharmaceutical Services Inc Second Quarter Earnings Result for 2020
05/05/2020 09:30 EDT Misc West Pharmaceutical Services Inc Annual General Meeting for 2019
04/23/2020 09:00 EDT Misc West Pharmaceutical Services Inc First Quarter Earnings Conference Call for 2020
04/23/2020 Earnings West Pharmaceutical Services Inc First Quarter Earnings Result for 2020
04/21/2020 Dividends Amount: 0.16, Declared Date: Feb 25 2020, Pay Date: May 06 2020
02/24/2020 Misc West Pharmaceutical Services Inc Annual Report for 2019
02/13/2020 09:00 EST Misc West Pharmaceutical Services Inc Fourth Quarter Earnings Conference Call for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.westpharma.com
  • Investor Relations URL: http://www.westpharma.com/en/Investors/Pages/default.aspx
  • HQ State/Province: Pennsylvania
  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Jul. 23, 2020
  • Last Earnings Release: Apr. 23, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Apr. 21, 2020
  • Description: West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (75% of 2019 sales) and contract-manufactured products (25%). The firm generates 56% of its revenue from international markets and 44% from the United States.

Top Fund Holders

Symbol Name Weighting
FRDRX Franklin Rising Dividends R 2.99%
BARUX Baron Asset R6 2.86%
NBGAX Neuberger Berman Genesis Adv 2.75%
PDP Invesco DWA Momentum ETF 2.54%
BMRRX BlackRock Mid-Cap Growth Equity R 2.28%
FXH First Trust Health Care AlphaDEX® ETF 1.96%
VISGX Vanguard Small Cap Growth Index Inv 0.95%
VBK Vanguard Small-Cap Growth ETF 0.95%
SCHM Schwab US Mid-Cap ETF™ 0.59%
NAESX Vanguard Small Cap Index Inv 0.49%
VB Vanguard Small-Cap ETF 0.49%
RSP Invesco S&P 500® Equal Weight ETF 0.23%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.